Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Ussat

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|October 10, 2002
Species-specific differences in the usage of several caspase substratesSandra Ussat, Ulf Werner, Sabine Adam-Klages
Experimental Cell Research|January 20, 2004
Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kappaB, elicits caspase activity, and enhances cytotoxicitySilke Lüschen, Gudrun Scherer, Sandra Ussat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteinsMarkus Falk, Sandra Ussat, Norbert Reiling, et al.
Experimental Cell Research|September 1, 2005
The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERKSilke Lüschen, Markus Falk, Gudrun Scherer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligandsHans-Heinrich Oberg, Thi Thuy Hoa Ly, Sandra Ussat, et al.
European Journal of Immunology|June 4, 2008
Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytesMaren Paulsen, Sandra Ussat, Marten Jakob, et al.
Biochemical and Biophysical Research Communications|June 12, 2002
Upregulation of p21(WAF1/Cip1) precedes tumor necrosis factor-induced necrosis-like cell deathSandra Ussat, Ulf-Eike Werner, Marie-Luise Kruse, et al.
Blood|August 23, 2017
Hematopoietic stem cell involvement in <i>BCR-ABL1-</i>positive ALL as a potential mechanism of resistance to blinatumomab therapyInga Nagel, Marius Bartels, Johannes Duell, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|October 10, 2002
Species-specific differences in the usage of several caspase substratesSandra Ussat, Ulf Werner, Sabine Adam-Klages
Experimental Cell Research|January 20, 2004
Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kappaB, elicits caspase activity, and enhances cytotoxicitySilke Lüschen, Gudrun Scherer, Sandra Ussat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteinsMarkus Falk, Sandra Ussat, Norbert Reiling, et al.
Experimental Cell Research|September 1, 2005
The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERKSilke Lüschen, Markus Falk, Gudrun Scherer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligandsHans-Heinrich Oberg, Thi Thuy Hoa Ly, Sandra Ussat, et al.
European Journal of Immunology|June 4, 2008
Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytesMaren Paulsen, Sandra Ussat, Marten Jakob, et al.
Biochemical and Biophysical Research Communications|June 12, 2002
Upregulation of p21(WAF1/Cip1) precedes tumor necrosis factor-induced necrosis-like cell deathSandra Ussat, Ulf-Eike Werner, Marie-Luise Kruse, et al.
Blood|August 23, 2017
Hematopoietic stem cell involvement in <i>BCR-ABL1-</i>positive ALL as a potential mechanism of resistance to blinatumomab therapyInga Nagel, Marius Bartels, Johannes Duell, et al.
Pageof 1